Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDraganfly Investments Regulatory News (DRG)

  • There is currently no data for DRG

Final Results

29 Jul 2009 17:14

RNS Number : 5210W
Draganfly Investments Ltd
29 July 2009
 



Draganfly Investments Limited (the "Company")

Final audited results

for the year ended 30 April 2009

Chairman's Statement

During the 12 months under review net assets have fallen from 2.45 pence per share on 30th April 2008 to 1.57 pence per share on 30th April 2009, a decline of 36% compared with the wider AIM market's decline of 51% during the same period. Details of the results for the year are given in the directors' report.

This performance primarily reflects the general weakness of global stock markets and, in particular, that of the AIM market during the period.

An additional factor was the Board's decision, in April 2009, to review the holding values of two private investments, Continental Petroleum Limited, and Finance Ireland. The holding value in Continental Petroleum Limited was reduced to the original entry price, reflecting the weakness in Russian markets and the protracted process for extending the company's exploration license. The company is due to update shareholders in the coming weeks. The holding in Finance Ireland was written off, resulting from a lack of access to capital in the wholesale money markets. This is very disappointing since the management team of Finance Ireland has an outstanding reputation and track record in Irish financial services and the Irish mortgage market in particular.  However, since the year end, the company has communicated to shareholders that value remains within the business and we look forward to further news in due course. The net impact of these events is a reduced portfolio holding value of £265,420.76.

Elsewhere amongst the private holdings, Microsaic Systems and Atlantic Healthcare continue to develop their businesses, and we look forward to significant progress from these companies during the coming year. Moreover, Sino Gas and Energy is in the process of preparing for a float on the Australian ASX market, and is making great strides in the development of its Chinese gas portfolio. Our research suggests that the company has resources significantly in excess of the valuation implied by the current holding price and we look forward to updating shareholders once further information is revealed. The impending flotation of Sino Gas and Energy is expected to make a significant positive impact on the overall liquidity position within your company's portfolio.

During the period under review we have sold our holdings in Braemore Resources and GB Group, and traded Rheochem, Medicsight, and Iofina where we retain shareholdings.  Since the year end we have added Sirius Exploration, a potash exploration and development company, to the portfolio, participating in the recent 2p placing round.

Overall, the general picture remains similar to the previous twelve months. The portfolio continues to outperform a difficult smaller company marketplace, but remains exposed to the harsh realities of the world economy and international stock markets. We remain confident that our shareholdings carry material value and re-rating potential, and hold true to the strategy of investing in companies with significant unrealised value, and cash/profit generating ability.

In our previous communication we referred to unprecedented levels of fund redemptions, and dislocation amongst the shareholder base of many of our investee companies, and the impact this has had on the portfolio performance. Whilst this pressure may have eased, the opportunity remains to seek out investments in companies which continue to suffer from distressed selling and a lack of access to capital for growth and restructuring. This position is enhanced by the acute lack of competition for deals in the current environment. 

Given the extent of this opportunity and the current scale of the Company's asset base, your Board is seeking opportunities to attract further funds and enlarge the business. 

May I take this opportunity to thank shareholders for their continued support.

Mark Horrocks

Chairman

 

Directors' Report

For the year ended 30 April 2009

The directors present their report for the year ended 30 April 2009.

Principal activity

The principal activity of the Company was as an investment trading and holding company.

Review of the business

The original investment brief is to run a small and focused portfolio of investments. The balance sheet total has fallen from £2,799,440 (2.45p per share) on 30 April 2008, to £1,788,404 (1.57p per share) on 30 April 2009. For year ended 30 April 2009 the company made a loss of £1,011,036 (2008 - loss of £212,189), which includes a realised net loss on sale of investments of £423,865 (2008 - gain of £183,212) and an unrealised loss on the company's investments of £325,539 (2008 - loss of £127,257).

The key performance indicator used to monitor the progress of the business is assets per share.

At 30 April 2009, the Company held nine investments, down from thirteen at 30 April 2008. Of these nine holdings, five were pre-IPO investments.

The Company has a credit facility to allow it to deliver continued improved returns to the shareholders. At 30 April 2009 the credit facility was not being utilised. The board is always alert to fresh investment opportunities but does not anticipate materially increasing the number of holdings at this stage. The board believes the current environment for small companies and pre-IPO investments remains very encouraging.

Dividends

The directors are unable to recommend payment of a dividend.

Risk management

Risks are considered across the following broad categories:

Strategic

Risks arising from the analysis, design and implementation of the company's business model, and key decisions on investment levels and capital allocation.

Investment

an investment or exposure concentrations across business sectors.

Treasury and funding

Risks arising from (i) uncertainty in market prices and rates, 

(ii) an inability to raise adequate funds to meet investment needs or meet obligations as they fall due, or

(iii) inappropriate capital structure.

Operational

Risks arising from inadequate or failed processes, people and systems or from external factors affecting these.

Risk management is managed and monitored by the board. Given their fundamental significance to the Company, investment and treasury and funding risks are managed by specific processes which are described below.

Investment risk

The Company invests across a range of economic sectors. The portfolio is subject to periodic reviews to ensure there is no undue exposure to any one sector. The valuation of the Company's unquoted portfolio and opportunities for realisation depend to some extent on stock market conditions and the buoyancy of the wider mergers and acquisitions market.

Treasury and funding risk

The Company's funding objective is that the funding of investment assets are primarily met from shareholders' funds.

Credit Risk

The Company's financial assets are unsecured investments, in which the board considers the maximum credit risk to be the carrying value of the asset. The portfolio is diversified and credit risk is managed on an asset specific basis.

Liquidity risk

At 30 April 2008 the Company had an overdrawn position of £184,048. During the financial period the company realised some of its investments but also responded to investment opportunities and as a result has cash at bank of £15,895 at 30 April 2009. The board continues to monitor the position closely.

Price risk

The valuation of unquoted investments depends upon a combination of market factors and the performance of the underlying asset. The Company currently does not hedge the market risk inherent in the portfolio but manages asset performance risk on an asset specific basis.

Interest rate risk

The Company invests in shares and other securities. The assets are funded with a mixture of mainly shareholders' funds and a bank overdraft. The board seeks to minimise interest rate exposure by minimising credit funding.

Currency exchange risk

The Company holds investments in different countries and currencies. There is therefore an inherent risk that exchange rate fluctuations will adversely affect the portfolio value. The board does not hedge this risk specifically as it believes that there is no exposure to any particular currency.

Payments of creditors

The Company aims to pay all suppliers within the payment terms negotiated with each individual supplier. At 30 April 2008 and 2009, there were no trade creditors payable.

Directors and their interests

The directors who served during the year and their interests in the company are as stated below:

Class of share

30/04/09

30/04/08

T E G Bayman

Ordinary shares

-

-

R L Pitcher

Ordinary shares

-

-

J P Hamilton

Ordinary shares

-

-

Edmonds

Ordinary shares

-

-

M Horrocks

Ordinary shares

5,666,667

5,666,667

Directors' responsibilities

The directors are responsible for preparing the director's report and financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period.

 In preparing these the directors are required to:

- select suitable accounting policies and apply them consistently;

- make judgements and estimates that are reasonable and prudent;

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping proper accounting records which disclose with reasonable accuracy at any time the financial position of the company and to enable them to ensure that the financial statements comply with the Companies (Jersey) Law 1991. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

The directors are responsible for the maintenance and integrity of the corporate and financial information included on the Company's website.

Legislation in Jersey governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Statement as to disclosure of information to Auditor

The directors who were in office on the date of approval of these financial statements have confirmed, as far as they are aware, that there is no relevant audit information of which the auditor is unaware. Each of the directors have confirmed that they have taken all the steps that they ought to have taken as directors in order to make themselves aware of any relevant audit information and to establish that it has been communicated to the auditor.

This report was approved by the Board on 28 July 2009 and signed on its behalf by

T E G Bayman

Director

Independent auditor's report to the members of Draganfly Investments Limited

We have audited the financial statements The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

This report is made solely to the company's members, as a body, in accordance with Article 10 of the Companies (Jersey) Law 1991. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Respective responsibilities of directors and auditors

The directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's (APB's) Ethical Standards for Auditors.

Scope of the audit 

A description of the scope of an audit of financial statements is provided on the APB's website at www.frc.org.uk/apb/scope/UKNP.

Opinion on the financial statements

In our opinion the financial statements:

give a true and fair view of the state of the company's affairs as at 30 April 2009 and of its loss for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies (Jersey) Law 1991.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Companies (Jersey) Law 1991 requires us to report to you if, in our opinion:

 
·; adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
·; the financial statements are not in agreement with the accounting records and returns; or
·; certain disclosures of directors’ remuneration specified by law are not made; or
·; we have not received all the information and explanations we require for our audit
 

John Warner (Senior Statutory Auditor)

For and on behalf of BAKER TILLY UK AUDIT LLP, Statutory Auditor 

Chartered Accountants12 Gleneagles CourtBrighton RoadCrawleyWest Sussex

RH10 6AD

28 July 2009

  

Profit and loss account 

for the year ended 30 April 2009

 
 
 
Continuing Operations
 
 
 
Year End 30/4/09
 
Year End 30/4/08
 
Notes
 
£
 
£
(Losses)/ gains on investments
 
 
(749,404)
 
55,955
Income
 
 
7,482
 
6,971
 
 
 
(741,922)
 
62,926
Administrative expenses
 
 
(258,449)
 
(258,042)
Operating loss
 
 
(1,000,371)
 
(195,116)
 
 
 
 
 
 
Interest payable and similar charges
 
 
 
 
(10,665)
 
 
(17,073)
Loss on ordinary activities
 
 
(1,011,036)
 
(212,189)
 
 
 
 
 
 
There are no recognised gains or losses other than those included in the profit and loss account.

Loss per share (pence)
 
 
 
 
 
 
 
 
 
 
 
Basic
2
 
(0.89)
 
(0.19)
Diluted
2
 
(0.89)
 
(0.19)

 

  

Balance sheet

as at 30 April 2009

30/04/09

30/04/08

£

£

£

£

Fixed assets

Investments

1,777,000

2,997,889

Current assets

Debtors

9,369

5,022

Cash at bank and in hand

15,895

-

25,264

5,022

Creditors: amounts falling due within one year

Creditors

(13,860)

(19,423)

Bank overdraft

-

(184,048)

(13,860)

(203,471)

Net current assets/ (liabilities)

11,404

(198,449)

Total assets less current liabilities

1,788,404

2,799,440

Net assets

1,788,404

2,799,440

Capital and reserves

Called up share capital

1,142,270

1,142,270

Share premium account

1,980,303

1,980,303

Profit and loss account

(1,334,169)

(323,133)

Equity shareholders' funds

1,788,404

2,799,440

The financial statements were approved and authorised for issue by the Board on 28 July 2009 and signed on its behalf by

Director

T E G Bayman

Cash flow statement

for the year ended 30 April 2009

Year ended 30/04/09

Year ended 30/04/08

£

£

Reconciliation of operating loss to net

cash outflow from operating activities

Operating loss

(1,000,371)

(196,462)

Realised loss /(gain) on sale of investments

423,865

(183,212)

Unrealised loss on revaluation of investments

325,539

127,257

(Increase) in debtors

(4,347)

(865)

(Decrease) in general creditors

(5,563)

(9,087)

Net cash outflow from operating activities

(260,877)

(262,369)

Cash flow statement

Net cash outflow from operating activities

(260,877)

(262,369)

Servicing of finance

(10,665)

(15,473)

Interest received

-

1,346

Capital expenditure and financial investment

471,485

(224,334)

Increase / (Decrease) in cash in the year

199,943

(500,830)

Reconciliation of net cash flow to movement in net funds/(debt)

Increase / (Decrease) in cash in the year

199,943

(500,830)

Net (debt) / funds at 1 May 2008

(184,048)

316,782

Net funds /(debt) at 30 April 2009

15,895

(184,048)

 

Notes to the financial statements

for the year ended 30 April 2009

1. Accounting policies

1.1. Accounting convention

The financial statements are prepared under the historical cost convention modified to include the  revaluation of fixed asset investments, and in accordance with applicable accounting standards.

1.2. Going concern basis of accounting

The Company has incurred an overall loss for the year of £1,011,036 but the directors have considered whether the going concern basis of accounting is appropriate and have concluded that the company has sufficient liquid assets in the form of listed investments to meet its obligations as they fall due for a period of at least twelve months from the date of approval of these financial statements. The cost of administration of the company are stable at approximately £260,000 per annum, and the value of the listed investments at the date of approval of these financial statements is approximately £426,000. This provides sufficient readily realisable resources for the company to continue in operation for about 20 months from balance sheet date, assuming there are no unforeseen costs or falls in value of the investments. Further, it is anticipated that over the next year to eighteen month some of the unquoted stocks will come to market giving further liquidity, and the directors are working on a strategy to increase the asset base and the liquidity within it.

1.3. Investments

After initial recognition, investments, which are classified as held for trading, are measured at fair  value.  Gains or losses on investments held for trading are recognised in the profit and loss account. 

1.4. Foreign currencies

 

The company's accounts are presented in sterling which is its functional currency. Transactions in foreign currencies are initially recorded at the rate of exchange prevailing at the date of the transaction. Assets and liabilities denominated in foreign currencies are retranslated at the balance sheet date with any exchange differences charged or credited to the profit and loss account.

1.5. Taxation

Following changes in legislation the company is treated as an International Service Entity ("ISE"). In order to be an ISE a company has to not form a link in a value chain belonging to the consumption of goods and services by individuals belonging to Jersey and must be included in a private list of ISE's maintained by a Jersey Trust Company being regulated by the JFSC under the financial services law. Pentera Trust Company Limited, administrators of the company, maintains a list which includes the company.

This status is renewable on an annual basis upon payment of a fee to the  Controller of Income Tax in Jersey, and it is the company's intention to maintain this status.

Consequently, no provision for taxation, either current or deferred has been made in these financial statements.

 

1.6. Financial instruments

Investments

The Company manages its investments with a view to profiting from the receipt of dividends and changes in fair value of investments. Therefore all quoted investments and unquoted equity investments are designated as at fair value through the profit or loss and carried in the balance sheet at fair value. All investments are initially recognised at the fair value of the consideration given plus acquisition costs associated with the investment and held at this value until it is appropriate to measure fair value on a different basis.

Investments are fair valued using quoted market prices, independent appraisals, discounted cash flow analysis or other appropriate valuation models at the balance sheet date.

Quoted investments are stated at bid prices at the balance sheet date.

 

Unlisted investments are stated at 'price of recent investment', reflecting the early stage nature of the investment. The following considerations are used when calculating the 'price of recent investment' in accordance with the International Private Equity and Venture Capital Valuation Guidelines, published in October 2006, which have superseded the BVCA guidelines previously used. No change in the actual bases of valuation has been made.

Where the investment being valued was itself made recently, its cost will generally provide a good indication of fair value.

Where there has been a recent investment by third parties, the price of that investment will provide a  basis of the valuation.

Where a fair value cannot be estimated reliably, the investment is reported at cost or the carrying value at the previous reporting date, unless there is evidence that the investment has since been impaired.

Cash and cash equivalents

Cash and cash equivalents are included in the balance sheet at cost. Cash and cash equivalents comprise cash at bank and in hand and short term deposits with an original maturity of three months or less.

 Interest-bearing loans and borrowings

All loans and borrowings are recognised initially at cost, which is the fair value of the  consideration  received.

Short term debtors and creditors

Short term debtors and creditors are measured at cost and are excluded from the financial instrument disclosures.

2. Earnings per share

The basic earnings per ordinary share is calculated by dividing profit for the year less non-equity dividends and other appropriations in respect of non-equity shares by the weighted average number of equity shares outstanding during the year.

The diluted earnings per ordinary share is calculated by dividing profit for the year less non-equity dividends and other appropriations in respect of non-equity shares by the weighted average number of equity shares outstanding during the year (after adjusting both figures for the effect of dilutive potential ordinary shares).

 

The calculation of basic earnings per ordinary share is based upon the following data:

Earnings

2009

2008

£

£

Earnings for the purposes of basic earnings per share and diluted earnings per share

(1,011,036)

(212,189)

Number of shares

2009

2008

£

£

Basic weighted average number of shares

114,227,000

114,227,000

Weighted average number of shares

for the purposes of diluted earnings per share

114,227,000

114,227,000

There have been no transactions involving ordinary shares or potential ordinary shares since the reporting date and before the approval of these financial statements.

3. The Company will be posting its Annual Report and Accounts for the year ended 30 April 2009 along with Notice of the AGM to shareholders in due course. The Company's Annual Report and Accounts will be available to view and download on the Company's website at www.draganflyinvestments.com

For further information:

 

T Edward G Bayman
 +44 (0)1534 787898
Dennis Edmonds
 07796 338 372
 
 
Draganfly Investments Limited
 
 
 
Clive Carver
 
FinnCap (Nominated Advisor) +44 (0)20 7600 1658

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SEAFIUSUSEIW
Date   Source Headline
8th Aug 20184:05 pmRNSNet Asset Value
25th Jul 20189:19 amRNSRelated Party Transaction - CLN of £60,000
12th Jul 20182:00 pmRNSChange of Adviser
1st Jun 20183:16 pmRNSTransaction Update
3rd May 20183:23 pmRNSNet Asset Value(s)
22nd Mar 20188:10 amRNSTransaction Update
22nd Mar 20187:30 amRNSSuspension - Draganfly Investments Limited
12th Mar 20187:00 amRNSFundraising
5th Mar 20184:20 pmRNSAppointment of Broker
2nd Feb 20183:58 pmRNSNet Asset Value(s)
13th Dec 20175:07 pmRNSHalf-year Report
24th Nov 201712:56 pmRNSResult of AGM
7th Nov 20175:11 pmRNSNet Asset Value(s)
3rd Nov 20175:16 pmRNSHolding(s) in Company
27th Oct 20177:00 amRNSFinal Results
23rd Oct 201710:37 amRNSHolding(s) in Company
21st Aug 20179:08 amRNSDirectors' Disclosures
9th Aug 20174:38 pmRNSNet Asset Value(s)
3rd Aug 20177:00 amRNSBoard Appointment
31st May 201710:25 amRNSGrant of Options
30th May 20174:02 pmRNSBoard Appointment
24th May 20178:30 amRNSHolding(s) in Company
23rd May 20171:04 pmRNSNet Asset Value(s)
8th May 20179:11 amRNSFundraising
12th Apr 201711:06 amRNSResult of EGM
21st Mar 20172:10 pmRNSUpdate and Notice of EGM
17th Feb 201711:03 amRNSNet Asset Value(s)
31st Jan 201711:51 amRNSInterim Results
23rd Nov 20163:36 pmRNSResult of AGM
7th Nov 20169:35 amRNSNet Asset Value(s)
28th Oct 20165:01 pmRNSNotice of AGM
26th Oct 20167:00 amRNSAnnual Results
7th Oct 20167:00 amRNSLoan agreement
23rd Sep 20164:37 pmRNSNet Asset Value(s)
22nd Sep 20164:00 pmRNSFundraise
19th Jul 201612:20 pmRNSHolding(s) in Company
14th Jul 201612:20 pmRNSGM Result and Fundraise Update
27th Jun 20168:37 amRNSNet Asset Value(s)
24th Jun 20167:00 amRNSNotice of GM
18th Mar 20163:50 pmRNSReplacement - Appointment of Broker
18th Mar 20161:02 pmRNSAppointment of Broker
5th Feb 20161:11 pmRNSNet Asset Value(s)
29th Jan 20162:29 pmRNSInterim Results
27th Nov 201511:48 amRNSResult of AGM
11th Nov 20157:00 amRNSNotice of AGM
6th Nov 201510:16 amRNSNet Asset Value(s)
30th Oct 20157:00 amRNSFinal Results
6th Aug 20152:58 pmRNSNet Asset Value(s)
15th Jul 20157:00 amRNSInvestment Manager
5th May 20153:07 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.